Company: ARTL
Filing Date: 2025-12-11
Form Type: DEF 14A
Source: 0001640334-25-002308
Chunk: 27

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-12-11
Form: DEF 14A
Chunk 27
---
 | -2 |     |       | 88,505 |
| Douglas Blayney, M.D.(4)         |     |             | 48,000 |     |        | 10,452 | -2 |     |       | 58,452 |
| Gregory R. Reyes, M.D., Ph.D.(5) |     |             | 45,000 |     |        |  5,630 | -2 |     |       | 50,630 |
| R. Martin Emanuele, Ph.D.(6)     |     |             | 44,000 |     |        | 10,136 | -2 |     |       | 54,136 |
| Steven Kelly(7)                  |     |             | 59,500 |     |        | 10,956 | -2 |     |       | 70,456 |
| Tamara A. Favorito(8)            |     |             | 60,000 |     |        |  3,251 | -2 |     |       | 63,251 |

| (1) | In accordance with SEC rules, the amounts shown reflect the aggregate grant date fair value of stock awards granted to Non-Employee Directors during 2024, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (“FASB ASC 718”). The grant date fair value for stock options is measured based on the Black-Scholes Model. See Note 5 - Equity to our audited financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 3, 2025.       |
| (2) | On February 28, 2024, all previously issued options held by each non-employee director were repriced to $9.30 and had their vesting schedules modified as described in the “Executive Compensation” section below under “Repricing and Revesting Amendment”. As per ASC 718 the changes were treated as modifications to the options. The incremental fair value of the modification, computed as of the February 28, 2024 modification date in accordance with ASC 718, for each of the non-employee directors is listed below and is included in the “Option Awards” column. |

|                               |     | Incremental Fair Value of Options Repriced |        |
| Name                          |     | -$                                         |        |
| Connie Mats